Originally published In Press as doi:10.1074/jbc.M106006200 on August 9, 2001
J. Biol. Chem., Vol. 276, Issue 46, 43413-43418, November 16, 2001
Heterologous Expression of the Transcriptional
Regulator Escargot Inhibits Megakaryocytic Endomitosis*
Alicia
Ballester
,
Jonathan
Frampton§,
Nuria
Vilaboa
¶, and
Carmela
Calés
From the
Department of Biochemistry, Instituto de
Investigaciones Biomédicas "Alberto Sols," Universidad
Autónoma-Consejo Superior de Investigaciones Científicas,
Arturo Duperier 4, 28029 Madrid, Spain and the § Weatherall
Institute of Molecular Medicine, John Radcliffe Hospital, Headington,
Oxford OX3 9DS, United Kingdom
Received for publication, June 28, 2001, and in revised form, July 31, 2001
 |
ABSTRACT |
Certain cell types escape the strict mechanisms
imposed on the majority of somatic cells to ensure the faithful
inheritance of parental DNA content. This is the case in many embryonic
tissues and certain adult cells such as mammalian hepatocytes and
megakaryocytes. Megakaryocytic endomitosis is characterized by repeated
S phases followed by abortive mitoses, resulting in mononucleated
polyploid cells. Several cell cycle regulators have been proposed to
play an active role in megakaryocytic polyploidization; however, little is known about upstream factors that could control endomitosis. Here we
show that ectopic expression of the transcriptional repressor escargot interferes with the establishment of
megakaryocytic endomitosis. Phorbol ester-induced polyploidization was
inhibited in stably transfected megakaryoblastic HEL cells
constitutively expressing escargot. Analysis of the
expression and activity of different cell cycle factors revealed that
Escargot affects the G1/S transition by influencing
Cdk2 activity and cyclin A transcription. Nuclear proteins that
specifically bind the Escargot-binding element were detected in
endomitotic and non-endomitotic megakaryoblastic cells, but
down-regulation occurred only during differentiation of cells that
become polyploid. As Escargot was originally implicated in ploidy
maintenance of Drosophila embryonic and larval cells, our results suggest that polyploidization in megakaryocytes might respond
to mechanisms conserved from early development to adult cells that need
to escape normal control of the diploid state.
 |
INTRODUCTION |
In most somatic cells, the ploidy of progeny is maintained by
tightly controlling the proper alternation of DNA replication and
mitosis. However, polyploidization occurs in different cell types from
plants to vertebrates as part of their physiological differentiation
programs. For instance, most embryonic cells that do not give rise to
adult structures are highly polyploid, probably as a means to
potentiate the high metabolic rate needed to sustain the developing
embryo (1). In adult tissues, a few highly differentiated and mature
cells also appear to require an increase in DNA content, as is the case
for mammalian hepatocytes and the platelet precursor cell, the
megakaryocyte. In the final stages of maturation, megakaryoblasts stop
proliferating and undergo from three to five truncated cell cycles,
resulting in polyploid, fully mature megakaryocytes.
To increase their DNA content to levels up to 128N,
megakaryocytes repeatedly enter S phase after escaping mitosis without completing anaphase in a process traditionally called endomitosis (2,
3). In vitro and in vivo experimental approaches
have shown that both G1/S and G2/M cell cycle
transitions have to be regulated for megakaryocytes to achieve
polyploidization (4-12). Specifically, both cyclin D3-Cdk2 and cyclin
E-Cdk2 complexes have been proposed as the most likely candidates to
drive megakaryocytic polyploidization (4, 11, 12). However, little is
known about the mechanisms upstream of the cell cycle machinery that ultimately control the proper establishment of endomitotic cycles in
differentiating megakaryoblasts.
In embryonic systems, the entrance into re-replication cycles seems to
be inhibited by proteins belonging to the Snail family of
transcriptional repressors (for recent reviews, see Refs. 13 and 14).
All Snail proteins contain four to six highly conserved zinc fingers at
the C terminus of the protein through which they bind DNA. In
vitro binding site selection experiments using pools of random
sequences have revealed that the consensus binding element corresponds
to an E2 box that is recognized by a variety of basic helix-loop-helix
transcriptional activators. It has been proposed that the Snail
proteins may compete directly with basic helix-loop-helix proteins for
the same binding sequences, although this has been observed only in a
limited number of cases (19, 20). Genetic studies in
Drosophila, Xenopus, Caenorhabditis
elegans, and mouse have shown that Snail proteins participate in a
variety of processes that include mesoderm determination, neurogenesis,
and apoptosis (13, 14). More recently, Snail proteins have been
implicated in the invasiveness of cancer cells (15, 16) and in the
development of B lymphomas (17), revealing that they might have
important roles in adult tissues.
Escargot was first described in relation to the control of
Drosophila imaginal cell development (18). Further analysis
revealed that Escargot is involved in the maintenance of diploidy in
embryonic and larval cells (19). Thus, ectopic expression of
escargot inhibits polyploidization in salivary glands,
whereas its ablation prevents the regular progression through mitotic
cycles in the imaginal tissues and, as a result, causes abdominal
histoblasts to undergo endocycles and become polyploid (18, 19).
Interestingly, Escargot inhibits polyploidization of murine trophoblast
giant cells as efficiently as its murine homolog, Snail (20). In
addition, the endogenous expression pattern of both escargot
and snail further suggests an inhibitory activity on
Drosophila and mouse embryonic endocycles, respectively, as
both proteins are down-regulated in those cells that become polyploid
(18, 20).
Here we have asked whether a similar role could be played by proteins
related to Escargot in megakaryocytic endomitosis. The megakaryoblastic
cell line HEL normally responds to the phorbol ester
TPA1 by undergoing terminal
differentiation including polyploidization. We have isolated stable
clones of HEL cells constitutively expressing escargot and
monitored their response to TPA in terms of differentiation marker
expression, extent of polyploidization, and expression and activity of
different cell cycle regulators. In addition, we have explored whether
the presence of endogenous Escargot-like proteins capable of
specifically binding to an Escargot-binding element (EBE) correlates
with the ability of megakaryoblastic cells to become polyploid.
Our results show that escargot expression interferes with
the regulation of the G1/S transition of endomitotic cycles
and thereby with megakaryocytic polyploidization. They also suggest
that down-regulation of proteins that specifically interact with the
EBE could be required for megakaryoblastic cells to become polyploid.
 |
MATERIALS AND METHODS |
Cell Culture--
Cells were cultured in RPMI 1640 medium
supplemented with 10% (v/v) fetal calf serum (BioWhittaker), 2 mM L-glutamine, and 60 mg/ml gentamycin. Cells
were maintained at 37 °C under 5% CO2 and 95% air in a
humidified incubator. In all experiments, exponentially growing cells
were subcultured into Nunc 96-, 24-, or 6-well plates with or without
appropriate treatment. The number of viable cells was determined by
trypan blue exclusion in a hemocytometer chamber. To induce
megakaryocytic differentiation, 0.15-0.20 × 106
cells/ml were grown in the presence or absence of 10
8
M TPA (Sigma) for the indicated times.
Constructs and Oligonucleotides--
Full-length
escargot DNA was obtained from Dr. Mary Whiteley.
Expression vector pcDNA3-ESG was generated by subcloning an XbaI fragment containing the ESG open reading frame into the
pcDNA3 polycloning site (Invitrogen). The construction of the
cycA(
875)luc reporter plasmid containing the human cyclin A promoter
has been described elsewhere (11).
Transfection and Isolation of escargot-expressing HEL
Cells--
HEL cells (American Type Culture Collection) were
transfected by electroporation at 125 microfarads/300 V in a 0.4-cm
cuvette. 5 × 106 cells were transfected with 5 µg
of linearized pcDNA3 or pcDNA3-ESG plasmids. After 24 h,
cells were washed with phosphate-buffered saline and resuspended in
fresh medium supplemented with 500 µg/ml G418 antibiotic (Life
Technologies, Inc.). Cells were subcultured in 96-well plates at 1 × 105 cells/ml. Single cell clones were isolated by
limiting dilution of the G418-resistant cells.
For transient transfection experiments, cell lines were transfected by
electroporation. 2 × 106 cells were transfected with
2.5 µg of plasmid DNA by electroporation. For TPA treatments,
electroporated cells were divided into two aliquots and allowed to
recover for 12 h. One aliquot was then treated with TPA. 48 h
after electroporation, the cells were harvested, and cell extracts for
assaying luciferase activity were made by three cycles of freeze-thaw lysis.
Phenotypic Characterization of Cells--
Morphological Wright
stain was performed on cytospun cells. Cell-surface immunofluorescent
staining was performed by incubating cells with antibodies against
glycoprotein IIIa/CD61 or glycophorin A conjugated to FITC (Becton
Dickinson) as previously described (11). DNA content was determined by
staining with 50 µg/ml propidium iodide. Cell cycle analysis was
performed using a FACScan analyzer using CellQuest software (Becton Dickinson).
Mobility Gel Shift Analysis--
Nuclear extracts were
obtained by lysing cells in high salt buffer as previously described
(30). Binding reactions were carried out for 20 min at room
temperature in binding buffer (20% glycerol, 1 mM
dithiothreitol, 20 mM HEPES (pH 7.9), 5 mM
MgCl2, and 0.2 mM EDTA) containing 0.02 pmol of
32P-labeled oligomer, various amounts of protein extracts
as indicated, 40 µg/ml poly(dI-dC), and 100 mM
KCl. When needed, competitor oligonucleotides were added in excess to
the binding reaction. The probe or wild-type competitor (EBE) was
GCGGCCTGACAGGTGCTTTG. The mutant competitor (EBEM) was
GCGGCCTGCACACTGCTTTG, and the non-related competitor was GCGGCCTGCGTTACCTTTG. DNA-protein complexes were separated from unbound
labeled oligonucleotide on 6% nondenaturing polyacrylamide gels in
Tris borate/EDTA buffer. After drying, the shifted complexes were
visualized by autoradiography.
Immunoblotting--
Western blotting was performed as previously
described (11). Briefly, total cellular proteins were extracted in
lysis buffer (20 mM Tris-HCl (pH 7.4), 10 mM
EDTA, 100 mM NaCl, and 1% Triton X-100) containing
protease and phosphatase inhibitors. Protein extracts (30 µg) were
subjected to SDS-polyacrylamide gel electrophoresis, and gels were
transferred to BioTraceTM polyvinylidene difluoride
membranes (Pall Corp.) for 1 h at 2 mA/cm2 on a
semidry transfer apparatus (Amersham Pharmacia Biotech). After blocking
in 5% skim dry milk in Tris-buffered saline containing 0.1%
Tween 20 (TTBS), filters were incubated overnight at 4 °C with the
appropriate primary antibody diluted in TTBS. After washing and
incubation with goat anti-rabbit or goat anti-mouse IgG conjugated to
horseradish peroxidase (Dako), signals were detected using the enhanced
chemiluminescence system (Pierce).
Immunoprecipitation and Kinase Activity
Determination--
Extracts were isolated as described for Western
blot analyses. Total protein was incubated for 2 h at 4 °C in
the presence of anti-Cdk2 antibody. Immunocomplexes were then isolated
by the addition of 0.1 volume of 50% (v/v) protein A-Sepharose and
incubation for 2 h at 4 °C on a rotating wheel.
Immunoprecipitates were washed four times with 1 ml of ice-cold lysis
buffer and once with 1 ml of kinase buffer (50 mM Tris-HCl
(pH 7.4), 10 mM magnesium chloride, and 1 mM
dithiothreitol). Pellets were then resuspended in 40 µl of kinase
buffer with 250 ng of the carboxyl-terminal part of retinoblastoma
protein (Santa Cruz Biotechnology). Reactions were initiated by the
addition of 5 µM ATP and 10 µCi of
[
-32P]ATP (3000 Ci/mmol), incubated at 30 °C for 30 min, stopped by the addition of 4× Laemmli sample buffer, and boiled
for 5 min. 25 µl of each reaction was analyzed by SDS-polyacrylamide
gel electrophoresis on a 10% polyacrylamide gel, and bands were
detected by autoradiography.
Immunocytochemical Detection of Cyclins--
For the
simultaneous analysis of cell cycle and cyclin expression, cells were
washed with phosphate-buffered saline and fixed in suspension in cold
75% ethanol. After washing and permeabilization, cells were pelleted
and incubated with either FITC-conjugated anti-cyclin A antibody or
isotype control antibody or with anti-cyclin E antibody and an
appropriate irrelevant IgG1 control (all antibodies were obtained from
Pharmingen). Anti-cyclin E binding was detected after washing by
incubation with BODIPY-FL-conjugated goat anti-mouse IgG (Molecular Probes, Inc.). After appropriate washing, cells were labeled with propidium iodide in phosphate-buffered saline. Analysis was performed using a FACScan analyzer using CellQuest software.
 |
RESULTS |
Constitutive Expression of escargot Does Not Affect the Growth or
Morphology of Megakaryoblastic HEL Cells--
Endomitotic
megakaryoblastic HEL cells were transfected with full-length
Esg cDNA under the control of a cytomegalovirus
promoter. 10 clones were selected in the presence of G418 and analyzed
for the presence of functional ESG protein. Nuclear extracts of
transfectants were analyzed by electrophoretic mobility shift assays
using a labeled double-stranded oligonucleotide containing the
consensus binding site for ESG (ACAGGTG, hereinafter referred to as the EBE). As shown in Fig. 1a,
extracts from four of the clones transfected with the ESG-expressing
vector gave a pattern of shifted proteins that was not present
in a G418-resistant clone of HEL cells transfected with an empty
vector. The latter was subsequently used as control HEL (referred to as
HELc) cells. A similar pattern of protein-EBE complexes was observed in
COS cells transiently transfected with the same ESG-expressing
construct (Fig. 1c). The specificity of binding to the EBE
of proteins derived from the HEL/ESG clones was assessed by competing
with a 100-fold excess of the EBE oligonucleotide, a mutant version of
the EBE that does not bind to ESG (EBEM), or an
oligonucleotide containing an unrelated sequence. This revealed that
the two predominant complexes of higher mobility represented specific
complexes between the ectopically expressed ESG and EBE, whereas the
lower mobility complexes seen in both transfected and control clones
were nonspecific and unrelated to the presence of ESG (Fig.
1b). Based on these preliminary observations, the HEL/ESG
clones HA1 and HD12 were selected for further analysis.

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 1.
Isolation of
escargot-expressing megakaryoblastic HEL cells.
HEL cells were transfected with empty pcDNA3 or pcDNA3-ESG
plasmids and selected in G418 under the conditions described under
"Materials and Methods." a, 5 µg of nuclear extract
protein of 10 single cell clones derived from
pcDNA3-ESG-transfected cells (left panel) was randomly
chosen and analyzed for the presence of the ectopic DNA-binding protein
by electrophoretic mobility shift assay. The arrows show
EBE-bound bands due to overexpression of escargot. One of
the G418-resistant clones transfected with empty pcDNA3 (HELc) had
a pattern of EBE-bound proteins identical to that present in parental
HEL cells (right panel). b, the binding reaction
was carried out in the presence of an excess (100 times) of unlabeled
EBE or of EBEM using one of the
escargot-expressing clones chosen for further analysis
(HA1). c, COS cells were transfected with pcDNA3 or
pcDNA3-ESG plasmids, and the nuclear extracts were analyzed for the
presence of EBE-binding proteins. NRC, non-related
competitor.
|
|
To determine whether constitutive expression of ESG was affecting the
intrinsic phenotypic properties of HEL cells, clones HA1 and HD12 were
examined with respect to their proliferation under normal growth
conditions. In addition, the clones were tested for differentiation in
response to treatment with the phorbol ester TPA, which triggers the
differentiation of HEL cells, leading to decreased cell division and
acquisition of mature megakaryocytic features. Constitutive expression
of ESG did not affect the exponential growth of HEL cells in standard
growth medium or the growth arrest response to TPA (Fig.
2a). The morphology of
exponentially growing HELc and ESG-expressing clones was very similar,
with an immature morphology typical of erythroleukemic cells
(Fig. 2c). Likewise, the TPA-driven up-regulation of
megakaryocytic markers such as glycoprotein IIIa (CD61) and
down-regulation of the erythrocytic marker glycophorin A remained
unchanged in the ESG-expressing cells compared with HELc cells (Fig.
2b). The morphology of exponentially growing HELc and
ESG-expressing clones was very similar, with a blast morphology typical
of erythroleukemic cells (Fig. 2c). However, profound
differences were observed when HELc, HA1, and HD12 cells were treated
with TPA. Hence, a significant proportion of differentiated HELc cells
appeared as large cells with a polylobulated nucleus, whereas
ESG-expressing HEL cells showed no cytoplasmic or nuclear maturation
and the presence of large vacuoles in a high proportion of cells.
Therefore, it appeared that ESG was specifically interfering with the
completion of the TPA-driven megakaryocytic differentiation
program.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 2.
Constitutive expression of Escargot does not
alter the differentiation of HEL cells in response to TPA.
Selected clones expressing (HA1 and HD12) or not expressing
(HELc) escargot were seeded at 1.5 × 105
cells/ml and treated with 10 8 M TPA or left
untreated. a, at the indicated times, cells were harvested
and counted. b, shown are the results from flow cytometric
analysis of indirect immunofluorescence staining of untreated and
TPA-treated HELc, HA1, and HD12 cells with FITC-conjugated anti-CD61 or
anti-glycophorin A (Gly A) antibodies (solid
histograms) and control isotype antibody (empty
histograms). Vertical axis, relative number of cells;
horizontal axis, relative green fluorescence
(FL1) on a logarithmic scale. c, shown are the
results from Wright staining of untreated and TPA-treated HELc, HA1,
and HD12 cells (magnification × 630).
|
|
Escargot Interferes with Phorbol Ester-induced
Polyploidization--
Next we analyzed the nuclear DNA content of
TPA-treated cells to determine whether the key feature of
megakaryocytic maturation, i.e. the degree of
polyploidization, was also affected in the presence of ESG. Control and
ESG-expressing HEL clones were seeded at 1.5 × 105
cells/ml in the presence or absence of TPA and stained with propidium iodide 48 and 96 h after treatment. More than 50% of the HELc cells showed a DNA content of 4N or higher (10 and 1% of cells being
8N and 16N, respectively) 48 h after treatment, whereas HA1 and
HD12 cells failed to become polyploid even after 96 h in the
presence of TPA (Fig. 3). Instead, the
propidium iodide staining pattern indicated that ESG-expressing HEL
cells remained arrested in G1 and G2. This
behavior appeared to be reminiscent of megakaryoblastic K562 cells,
which respond to TPA in terms of platelet antigen up-regulation, but do
not become polyploid (Fig. 3). As Escargot DNA-binding properties were
not affected by the TPA treatment (data not shown), we conclude that
Escargot inhibits the establishment of endomitotic cycles in
megakaryoblastic cells.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 3.
Constitutive expression of
escargot interferes with HEL cell
polyploidization. Shown are the results from the propidium iodide
staining of HELc, HA1, HD12, and K562 cells untreated (exponentially
growing (E)) or treated with TPA for the indicated times.
Vertical axis, relative number of cells; horizontal
axis, relative red fluorescence (FL2) on a logarithmic
scale indicating the DNA content per cell. The positions of
peaks representing cells with a DNA content of 2C, 4C, 8C, and 16C are
indicated.
|
|
Escargot-mediated Inhibition of Megakaryocytic
Polyploidization Occurs through Alteration of the Endomitotic
G1/S Transition--
Establishment of endomitotic cycles
in HEL cells requires active cyclin E-Cdk2 complexes, which in turn
maintain cyclin A expression (11). We therefore analyzed the
G1/S machinery in HELc cells and ESG-expressing
clones before and after treatment with TPA. As shown in Fig.
4a, TPA treatment of HA1 and
HD12 cells resulted in a decrease in the levels of cyclins E and A and
Cdk2 activity, whereas p27kip1 inhibitor levels remained
unchanged or even increased. This was in sharp contrast with the
pattern of expression of these proteins in HELc cells, which showed the
expected maintenance of cyclin and p27kip1 levels and Cdk2
activity. Interestingly, the pattern of TPA-induced changes in HA1 and
HD12 cells resembled that in non-endomitotic K562 cells with the
exception that the ESG-expressing cells demonstrated a more dramatic
down-regulation of retinoblastoma protein. These data suggest that a
profound inhibition of the G1/S transition in TPA-treated
cells occurs in the presence of Escargot.

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 4.
Endomitotic G1/S transition is
affected by Escargot expression. a, cells were cultured
in the absence or presence of 10 8 M TPA. 30 µg of total protein extract from cells exponentially growing ( ) or
treated with TPA for 48 h (+) was subjected to SDS-polyacrylamide
gel electrophoresis and detected by Western blotting with antibodies
against the proteins indicated to the right of the upper
panel. The lower panel shows the Cdk2-associated kinase
activity assayed after immunoprecipitation from TPA-treated (+) and
untreated ( ) HELc, HA1, and HD12 extracts in the presence of
glutathione S-transferase-retinoblastoma protein
(Gst-pRb) and [ -32P]ATP. b, the
diagrams show the results from flow cytometric analysis of HA1 cells
either untreated (exponentially growing (E)) or treated with
TPA for 6, 12, 24, and 48 h (upper panel) and of HD12,
HELc, and K562 cells untreated or treated with TPA for 48 h
(lower panels). Expression of cyclins A and E was detected
by immunofluorescence using a FITC-conjugated anti-cyclin A antibody
(Cyc A) or anti-cyclin E/BODIPY-FITC-conjugated goat
anti-mouse IgG (Cyc E) (FL1, vertical
axis, linear scale). Total DNA content was monitored by propidium
iodide staining (FL2, horizontal axis, linear
(lin) scale). The positions of cells stained in parallel
with the isotype control are indicated by the overlaid
polygon.
|
|
To investigate in greater detail whether Escargot was affecting the
maintenance of expression of G1/S regulators during
TPA-driven differentiation, a time course bivariant flow cytometric
analysis was performed. Prior to TPA treatment, cyclins E and A were
present in G1/S and S/G2 cells, respectively,
as expected for exponentially growing cells (Fig. 4b,
t = 0). Subsequent to the addition of TPA, it appeared
that the level of both cyclins progressively declined for the first
24 h and that no cells expressed the proteins. In fact, 48 h
after differentiation, HA1 and HD12 lacked nuclear cyclins E and A, as
was also observed in K562 cells. In contrast, polyploid HELc cells
maintained waves of expression of the G1/S cyclins
(Fig. 4b). These results suggest that the cell populations that are entering S and M phases at the time of TPA treatment respectively progress through replication and mitosis during the first
hours of differentiation, but that no further G1/S
transition takes place in escargot-expressing HEL cells.
Escargot Affects the Transcriptional Regulation of Cyclin
A--
We have previously observed that TPA inhibits cyclin A
expression in non-endomitotic megakaryoblastic cells (e.g.
K562) and that ectopic expression of cyclin E enables these cells to
reestablish cyclin A expression and, as a consequence, to undergo
endomitotic replication (11). Therefore, a possible target for the
action of Escargot could be the transcriptional regulation of cyclin A
gene expression. To test this, HELc, HA1, and HD12 cells were transiently transfected with the cycA(
875)luc construct, which contains the luciferase reporter gene under the control of sequences from
875 to +37 base pairs of the human cyclin A promoter. Promoter activity was then assessed in the presence and absence of TPA. As we
had previously shown (11), the activity of the cyclin A promoter in HEL
cells was maintained or slightly increased in TPA-treated cells. In
contrast, TPA resulted in a >3-fold decrease in luciferase expression
in escargot-expressing cells (Fig.
5). This apparent inhibition of cyclin A
promoter activity in ESG-expressing HEL cells following TPA treatment
was similar to the degree of inhibition that was observed in
TPA-treated K562 cells (40% of activity compared with untreated
cells). These results are consistent with the idea that the mechanisms
by which Escargot blocks the establishment of endomitotic cycles in HEL
cells could be similar to those operating in non-endomitotic K562 cells
and may involve effects at the level of the regulation of cyclin A
gene expression.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 5.
Escargot inhibits cyclin A promoter
activity. 2 × 106 HELc, HA1, and HD12 cells were
transfected by electroporation with 2 µg of cycA( 875)luc reporter
constructs. TPA was added to half of the cells; and 48 h later,
cells were collected and assayed for luciferase activity. The
white and black bars represent untreated and
TPA-treated cells, respectively. The activity of the cyclin A promoter
has been arbitrarily set to a value of 1 for the exponentially growing
untreated aliquot of the three cell lines transfected; the values for
the activity obtained in the TPA-treated cells are then given relative
to this activity. The -fold stimulation of the promoter induced by TPA
is shown at the top.
|
|
Human Proteins That Bind to the Escargot DNA-binding Site Can Be
Detected in Non-endomitotic Cells--
The phenotypic similarities
between Escargot-expressing HEL cells and
non-endomitotic K562 cells suggested that endogenous Escargot-like
proteins could be present in these latter cells. To test this
possibility, electrophoretic mobility shift assays were performed on
nuclear extracts isolated from untreated or TPA-treated HEL and K562
cells. Under the conditions used to assess ectopic escargot
expression in transfected cells, no specific bands could be detected in
HELc cells (Fig. 1a) or K562 cells (data not shown).
However, when 2-3 times higher amounts of protein extract were used, a
major complex could be detected in both HEL and K562 cells (Fig.
6, upper left panel).
The specificity of the binding was estimated by competition with an
excess of unlabeled EBE or of EBEM (Fig. 6, lower
panels). A similar binding pattern was detected in a variety of
human cell types, including HeLa (epithelial), and U2OS (osteosarcoma)
cells (Fig. 6, upper right panel). Perhaps most
significantly, the amount of this specific complex was much higher in
electrophoretic mobility shift assays performed with extracts from K562
and the other cells analyzed compared with those using HEL extracts.
Interestingly, the amount of protein able to form this specific complex
with EBE remained constant, or even increased, in TPA-treated K562
cells, whereas it almost disappeared in differentiated endomitotic HEL
cells. These data indicate that human cells contain one or more nuclear
EBE-binding proteins. They also suggest that the presence of endogenous
EBE-binding proteins, like ectopically expressed escargot in
HEL, is not compatible with establishment of megakaryocytic endomitotic
cycles.

View larger version (92K):
[in this window]
[in a new window]
|
Fig. 6.
Nuclear extracts from human cells contain
proteins that bind to the Escargot-binding element. Upper
panels, nuclear extracts from TPA-treated (+) or untreated ( )
megakaryoblastic HEL and K562 cells and non-megakaryoblastic HeLa and
U2OS cells were incubated with labeled EBE, and the protein complexes
were analyzed by electrophoretic mobility shift assays as described
under "Materials and Methods." Reactions were carried out with 12 µg of protein, except for HA1 (5 µg). Lower
panels, the binding reaction was carried out in the presence of an
excess of unlabeled EBE or of EBEM (25, and 100 times as indicated) in HA1, K562, and HeLa cells. The black
arrows show the ectopic Escargot shifted complexes, and the
white arrow shows the specific endogenous EBE-bound
complex.
|
|
 |
DISCUSSION |
In this study, we have shown that constitutive
expression of the transcriptional repressor Escargot
inhibits megakaryocytic polyploidization. Previous genetic and
biochemical evidence had already demonstrated an inhibitory role for
Drosophila Escargot and murine Snail factors in the
establishment of endocycles in early development (19-21). The data
presented here extend this evidence and indicate that the
Drosophila protein retains its specific function in
re-replication control when expressed in adult mammalian cells. The
inhibition of endomitosis is also observed when mouse Snail is
ectopically expressed in HEL
cells,2 pointing to a general
role of certain members of the Snail family in the control of ploidy
maintenance. The cloning of a human homolog, SnaH, has recently been
reported (29). It could then be speculated that Escargot is affecting
target promoters physiologically controlled by the endogenous protein,
given the degree of homology between human and mouse proteins (overall
83%, reaching >95% identity in the DNA-binding region). Although the
binding elements that SnaH appears to preferentially recognize are not
coincident with the ones shown for its mouse homolog or Escargot (29),
it is important to bear in mind that these factors could bind to
variants of the sequences tested by in vitro random
selections. A putative target of Escargot relevant to megakaryocytic
endomitosis could be cyclin A: we have shown here that its expression
is down-regulated in escargot-expressing cells and that the
transcriptional activity of its proximal promoter region is
significantly reduced in these cells. Three E boxes that could account
for a repressive effect of Escargot/SnaH on the transcription of the
cyclin A gene are present in the proximal promoter region that was
present in our cyclin A promoter-reporter construct (CACTTG, CATATG,
and CAAGTG at
538,
469, and
387). Although none of these sites
corresponds to the consensus Escargot-binding element (19), it could be possible that the overexpressed heterologous protein binds in vivo to one or more of them. Work is in progress to investigate whether cyclin A is one of the putative Escargot target genes that
mediates its effect on endoreplication and to determine whether SnaH is
physiologically relevant to megakaryocytic polyploidization.
Another interesting point to take into account is that the
megakaryocytic endomitotic cycle presents substantial differences compared with embryonic endocycles. Although the latter consist of
successions of DNA duplication and short "gap" phases in which G2/M cyclins are absent (1, 22), megakaryocytes complete the G2 phase and enter an abortive mitosis lacking karyo-
and cytokinesis (23). However, despite these significant differences, our results suggest that mechanisms similar to those inhibited by
Escargot in embryonic cells may account for polyploidy in these highly
differentiated adult cells.
In all the systems analyzed to date, polyploidization is accompanied by
maintenance of an active G1/S transition and
down-regulation of the mitotic machinery (21, 24-27). In
megakaryocytic endomitosis, the G2/M transition takes place
in the presence of cyclin A and of active, albeit reduced, cyclin
B-Cdc2 complexes (3, 5, 10, 11, 28). Here we show that the
G1/S transition machinery, previously implicated in the
establishment of endomitosis in TPA-treated megakaryoblastic cells, is
inhibited in escargot-expressing cells. Thus, Cdk2 activity
is not detected in the differentiating escargot-expressing HEL cells, and this could result in the down-regulation of cyclin A. In
this respect, our data slightly differ from previous interpretations that Escargot/Snail specifically interfere with G2/M
machinery (20, 21). Thus, the inhibitory effect of Escargot and Snail was described to affect the obligate down-regulation of mitotic Cdc2
and cyclins A and B that occurs in embryonic endocycles (20, 21, 26,
27). We have also observed lower levels of cyclin B and also of Cdc2 in
escargot-expressing
cells,3 but our
interpretation is that the poor expression of these G2/M factors is an indirect consequence of the majority of cells not proceeding beyond G1. We believe that the key point at
which Escargot prevents HEL cells from proceeding into endomitotic
cycles lies in the regulation of the G1/S machinery, as a
profound down-regulation of cyclin E, Cdk2, and also of retinoblastoma
protein occurs in the overexpressing cells.
An additional observation is that the expression of escargot
in HEL cells results in a phenotype that is strikingly reminiscent of
non-endomitotic K562 cells. Hence, escargot-expressing cells respond to TPA by up-regulating megakaryocytic and concomitantly down-regulating erythrocytic markers, but do not undergo
polyploidization (11). This is also consistent with the idea that
Escargot-like proteins could be playing a determinant role in
megakaryocytic differentiation. It can then be hypothesized that K562
cells do not enter endomitosis because of the presence of a protein
functionally equivalent to Escargot, which would then be down-regulated
in differentiating HEL cells. Ectopic expression of escargot
in HEL cells might mimic an endogenous factor by interfering with the establishment of endomitotic cycles in these cells. The fact that EBE-binding proteins are present in TPA-treated K562 cells but absent
in HEL cells suggests that this could be the case. Although further
work is needed to determine whether the EBE-binding activities that we
have detected correspond to Snail factors or to another class of
DNA-binding proteins, the evidence presented in this study suggests
that megakaryocytic endomitotic differentiation could require the
down-regulation or inhibition of such E2 box-binding factors.
 |
ACKNOWLEDGEMENT |
We thank Dr. Rafael Bornstein for help in
morphological characterization of cells.
 |
FOOTNOTES |
*
This work was supported in part by Grant PM98-0046 from the
Ministry of Education and Grant CAM 08.3/0001/99 from the "Comunidad Autónoma de Madrid" (Spain) (to C. C.) and by a Wellcome Trust senior biomedical fellowship and a grant from the Association for
International Cancer Research (to J. F.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Supported by a postdoctoral fellowship from the "Comunidad
Autónoma de Madrid" (Spain).
To whom correspondence should be addressed. Tel.:
34-91-5854826; Fax: 34-91-5854587; E-mail: ccales@iib.uam.es.
Published, JBC Papers in Press, August 9, 2001, DOI 10.1074/jbc.M106006200
2
N. Vilaboa and C. Calés, unpublished observation.
3
A. Ballester and C. Calés, unpublished observation.
 |
ABBREVIATIONS |
The abbreviations used are:
TPA, 12-O-tetradecanoylphorbol-13-acetate;
EBE, Escargot-binding
element;
EBEM, mutant Escargot-binding element;
FITC, fluorescein isothiocyanate;
BODIPY-FL, 4,4- difluoro-4-bora-3
,4
-diaza-S-indacene.
 |
REFERENCES |
| 1.
|
Larkins, B. A.,
Dilkes, B. P.,
Dante, R. A.,
Coelho, C. M.,
Woo, Y.,
and Liu, Y.
(2001)
J. Exp. Bot.
52,
183-192[Abstract/Free Full Text]
|
| 2.
|
Nagata, Y.,
Muro, Y.,
and Todokoro, K.
(1997)
J. Cell Biol.
139,
449-457[Abstract/Free Full Text]
|
| 3.
|
Vitrat, N.,
Cohen-Solal, K.,
Pique, C.,
Le Couedic, J. P.,
Norol, F.,
Larsen, A. K.,
Katz, A.,
Vainchenker, W.,
and Debili, N.
(1998)
Blood
91,
3711-3723[Abstract/Free Full Text]
|
| 4.
|
Wang, Z.,
Zhang, Y.,
Kamen, D.,
Lees, E.,
and Ravid, K.
(1995)
Blood
86,
3783-3788[Abstract/Free Full Text]
|
| 5.
|
Garcia, P.,
and Calés, C.
(1996)
Oncogene
13,
695-703[Medline]
[Order article via Infotrieve]
|
| 6.
|
Zhang, Y.,
Wang, Z.,
and Ravid, K.
(1996)
J. Biol. Chem.
271,
4266-4272[Abstract/Free Full Text]
|
| 7.
|
Datta, N. S.,
Williams, J. L.,
Caldwell, J.,
Curry, A. M.,
Ashcraft, E. K.,
and Long, M. W.
(1996)
Mol. Biol. Cell
7,
209-223[Abstract]
|
| 8.
|
Zimmet, J. M.,
Ladd, D.,
Jackson, C. W.,
Stenberg, P. E.,
and Ravid, K.
(1997)
Mol. Cell. Biol.
17,
7248-7259[Abstract]
|
| 9.
|
Kikuchi, J.,
Furukawa, Y.,
Iwase, S.,
Terui, Y.,
Nakamura, M.,
Kitagawa, S.,
Kitagawa, M.,
Komatsu, N.,
and Miura, Y.
(1997)
Blood
89,
3980-3990[Abstract/Free Full Text]
|
| 10.
|
Datta, N. S.,
Williams, J. L.,
and Long, M. W.
(1998)
Cell Growth Differ.
9,
639-650[Abstract]
|
| 11.
|
Garcia, P.,
Frampton, J.,
Ballester, A.,
and Calés, C.
(2000)
Oncogene
19,
1820-1833[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Matsumura, I.,
Tanaka, H.,
Kawasaki, A.,
Odajima, J.,
Daino, H.,
Hashimoto, K.,
Wakao, H.,
Nakajima, K.,
Kato, T.,
Miyazaki, H.,
and Kanakura, Y.
(2000)
J. Biol. Chem.
275,
5553-5559[Abstract/Free Full Text]
|
| 13.
|
Hemavathy, K.,
Ashraf, S. I.,
and Ip, Y. T.
(2000)
Gene (Amst.)
257,
1-12[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Manzanares, M.,
Locascio, A.,
and Nieto, M. A.
(2001)
Trends Genet.
17,
178-181[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Batlle, E.,
Sancho, E.,
Franci, C.,
Dominguez, D.,
Monfar, M.,
Baulida, J.,
and Garcia De Herreros, A.
(2000)
Nat. Cell. Biol.
2,
84-89[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Cano, A.,
Perez-Moreno, M. A.,
Rodrigo, I.,
Locascio, A.,
Blanco, M. J.,
del Barrio, M. G.,
Portillo, F.,
and Nieto, M. A.
(2000)
Nat. Cell. Biol.
2,
76-83[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Inukai, T.,
Inoue, A.,
Kurosawa, H.,
Goi, K.,
Shinjyo, T.,
Ozawa, K.,
Mao, M.,
Inaba, T.,
and Look, A. T.
(1999)
Mol. Cell
4,
343-352[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Hayashi, S.,
Hirose, S.,
Metcalfe, T.,
and Shirras, A. D.
(1993)
Development
118,
105-115[Abstract]
|
| 19.
|
Fuse, N.,
Hirose, S.,
and Hayashi, S.
(1994)
Genes Dev.
8,
2270-2281[Abstract/Free Full Text]
|
| 20.
|
Nakayama, H.,
Scott, I. C.,
and Cross, J. C.
(1998)
Dev. Biol.
199,
150-163[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Hayashi, S.
(1996)
Development
122,
1051-1058[Abstract]
|
| 22.
|
Cayirlioglu, P.,
and Duronio, R. J.
(2001)
Curr. Biol.
11,
R178-R181[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Roy, L.,
Coullin, P.,
Vitrat, N.,
Hellio, R.,
Debili, N.,
Weinstein, J.,
Bernheim, A.,
and Vainchenker, W.
(2001)
Blood
97,
2238-2247[Abstract/Free Full Text]
|
| 24.
|
Grafi, G.,
and Larkins, B. A.
(1995)
Science
269,
1262-1264[Abstract/Free Full Text]
|
| 25.
|
Lilly, M. A.,
and Spradling, A. C.
(1996)
Genes Dev.
10,
2514-2526[Abstract/Free Full Text]
|
| 26.
|
MacAuley, A.,
Cross, J. C.,
and Werb, Z.
(1998)
Mol. Biol. Cell
9,
795-807[Abstract/Free Full Text]
|
| 27.
|
Palazon, L. S.,
Davies, T. J.,
and Gardner, R. L.
(1998)
Mol. Hum. Reprod.
4,
1013-1020[Abstract/Free Full Text]
|
| 28.
|
Zhang, Y.,
Wang, Z.,
Liu, D. X.,
Pagano, M.,
and Ravid, K.
(1998)
J. Biol. Chem.
273,
1387-1392[Abstract/Free Full Text]
|
| 29.
|
Okubo, T.,
Truong, T. K., Yu, B.,
Itoh, T.,
Zhao, J.,
Grube, B.,
Zhou, D.,
and Chen, S.
(2001)
Cancer Res.
61,
1338-1346[Abstract/Free Full Text]
|
| 30.
|
Frampton, J.,
McNagny, K.,
Sieweke, M.,
Philip, A.,
Smith, G.,
and Graf, T.
(1995)
EMBO J.
14,
2866-2875[Medline]
[Order article via Infotrieve]
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Vilaboa, R. Bermejo, P. Martinez, R. Bornstein, and C. Cales
A novel E2 box-GATA element modulates Cdc6 transcription during human cells polyploidization
Nucleic Acids Res.,
December 8, 2004;
32(21):
6454 - 6467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bermejo, N. Vilaboa, and C. Cales
Regulation of CDC6, Geminin, and CDT1 in Human Cells that Undergo Polyploidization
Mol. Biol. Cell,
November 1, 2002;
13(11):
3989 - 4000.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.